MPTs: Articles
from the Field

Issue #11 - 17 March 2015


To our IMPT/CAMI Health Colleagues,


The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies, and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.


If you have a resource to include in our next issue, please send to Beverley Newman at [email protected]. Previous issues are available on the CAMI Health website.     




CAMI Health Staff 

Journal Articles



Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012. Wall, K.M., Kilembe, W., Vwalika, B., Khu, N.H., Brill, I., et al. (2015). Contraception.


'Men don't need to know everything': a field trial of a discreet, female initiated, contraceptive barrier method (FemCap™) among Haitian-American women. Gollub, E.L., Cyrus, E., Devieux, J.G., Jean-Gilles, M., Neptune, V., et al. (2015). Culture, Health & Sexuality: An International Journal for Research, Intervention and Care.


Prevalence of sexually transmitted infections including HIV in street-connected adolescents in western Kenya. Winston, S., Chirchir, A., Muthoni, L., Ayuku, D., Koech, J., et al. (2015). Sexually Transmitted Infections. 

Media Articles


ARV trial just won't gel. Cullinan, K. (2015, February 25). IOL. 


Blame research design for failed HIV study. Susser, I. (2015, March 5). Al Jazeera America.  


Block That Sperm! Khazan, O. (2015, February 16). The Atlantic.   


Controversy around tenofovir gel. Ngobese, N. (2015, March 5). ECHO. 


CROI 2015: Maraviroc Levels in Vaginal and Rectal Tissues May Not Be High Enough for PrEP. Highleyman, L. (2015, March 2).


CROI 2015: PrEP, microbicide findings show divergent paths of prevention responses. Barton, A. (2015, February 24.) Science Speaks.  


Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use. Cairns, G. (2015, February 25). AIDSmap. 


Gel to Prevent HIV Infection Fails -- Again. Susman, E. (2015, February 25). MedPage Today.  


Make HIV prevention happen for young women. Rosenberg, Z. & Hillier, S. (2015, March 6). Devex. 


New Pregnancy HIV Prevention Tools On The Way. Ombati, E. (2015, February 23). The Star.   


Study That Paid Patients to Take H.I.V. Drugs Fails. McNeil Jr., D.G. (2015, February 24). The New York Times. 


U.S. Push for Abstinence in Africa Is Seen as Failure Against H.I.V. McNeil Jr., D.G. (2015, February 26). The New York Times.   


Vaginal gel won't protect women against HIV. Koka, J. (2015, February 24). Mail & Guardian.  


Women Deserve to Know About HIV Prevention Medication Too. Forbes, A., Chatani, M., & Dixon Diallo, D. (2015, March 10). RH Reality Check.  



AVAC Report 2014/15: HIV Prevention on the Line. (2015). AVAC.  


USAID Health-Related Research and Development Progress Report. (2014). Bureau for Global Health, United States Agency for International Development (USAID).  

Press Releases


Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years. (2015, February 27). Actavis and Medicines360.


AVAC calls for rapid response to new ARV-based HIV prevention data presented at CROI, including expedited regulatory review, expanded rollout and updated research plans. (2015, February 24). AVAC.


Daily Dosing May Foster More Sustained Use of PrEP by African Women to Prevent HIV. (2015, February 24). HIV Prevention Trials Network.


FACTS Trial Results Inform Multipurpose Prevention Technology (MPT) Development. (2015, February 25). CAMI Health.


HIV prevention study does not confirm tenofovir gel effectiveness. (2015, February 24). Follow-on African Consortium for Tenofovir Studies (FACTS). 

Visit and
for more resources on MPTs.

Facebook   Twitter

IMPT Secretariat: CAMI Health

312 Natoma Street, Suite 150
Folsom, CA 95630
[email protected]